“Clinical abnormalities seen in people with obesity-related type 2 diabetes [...] are a mixture of consequences of inadequate insulin action, excessive insulin action and adipose failure.” This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.